17β-Hydroxysteroid Dehydrogenase Type 1 Stimulates Breast Cancer by Dihydrotestosterone Inactivation in addition to Estradiol Production
暂无分享,去创建一个
D. Poirier | Sheng-Xiang Lin | M. Mazumdar | J. A. Aka | Juliette A. Aka | Sheng-Xiang Lin | Donald Poirier | Changqing Chen | Juliette A Aka | Mausumi Mazumdar | Chang-Qing Chen | Chang-Qing Chen
[1] M. Nakashima,et al. IL-11 up-regulates Tie-2 expression during the healing of gastric ulcers in rats. , 2003, World journal of gastroenterology.
[2] J. Fontecilla-Camps,et al. The structure of a complex of human 17beta-hydroxysteroid dehydrogenase with estradiol and NADP+ identifies two principal targets for the design of inhibitors. , 1996, Structure.
[3] T. Penning,et al. Human cytosolic 3alpha-hydroxysteroid dehydrogenases of the aldo-keto reductase superfamily display significant 3beta-hydroxysteroid dehydrogenase activity: implications for steroid hormone metabolism and action. , 2003, The Journal of biological chemistry.
[4] Janine T. Lin,et al. Global Transcriptional Response of Bacillus subtilis to Treatment with Subinhibitory Concentrations of Antibiotics That Inhibit Protein Synthesis , 2005, Antimicrobial Agents and Chemotherapy.
[5] J. Ferlay,et al. Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.
[6] R. Santen,et al. In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway. , 1984, The Journal of clinical endocrinology and metabolism.
[7] Sheng-Xiang Lin,et al. Reductive 17β-hydroxysteroid dehydrogenases in the sulfatase pathway: Critical in the cell proliferation of breast cancer , 2009, Molecular and Cellular Endocrinology.
[8] M. Beato,et al. Regulation of androgen receptor mRNA and protein level by steroid hormones in human mammary cancer cells , 1992, The Journal of Steroid Biochemistry and Molecular Biology.
[9] F. Labrie,et al. Additive inhibitory effects of an androgen and the antiestrogen EM-170 on estradiol-stimulated growth of human ZR-75-1 breast tumors in athymic mice. , 1991, Cancer research.
[10] W. Tilley,et al. Role of the Androgen Receptor in Human Breast Cancer , 2004, Journal of Mammary Gland Biology and Neoplasia.
[11] B. Xiao,et al. Decursin and decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells , 2007, Breast Cancer Research.
[12] D. Ghosh,et al. Structure and function of 17β-hydroxysteroid dehydrogenase type 1 and type 2 , 2001, Molecular and Cellular Endocrinology.
[13] J. Pasqualini,et al. Importance of estrogen sulfates in breast cancer. , 1989, Journal of steroid biochemistry.
[14] J. Gustafsson,et al. Influence of Cellular ERα/ERβ Ratio on the ERα-Agonist Induced Proliferation of Human T47D Breast Cancer Cells , 2008, Toxicological sciences : an official journal of the Society of Toxicology.
[15] D. Poirier,et al. Inhibitors of type 1 17β-hydroxysteroid dehydrogenase with reduced estrogenic activity: Modifications of the positions 3 and 6 of estradiol , 2005, Journal of enzyme inhibition and medicinal chemistry.
[16] A. Sasco. Breast Cancer and the Environment , 2003, Hormone Research in Paediatrics.
[17] M. Poutanen,et al. Role of 17β-hydroxysteroid dehydrogenase type 1 in endocrine and intracrine estradiol biosynthesis , 1995, The Journal of Steroid Biochemistry and Molecular Biology.
[18] M. Kirschner. The Role of Hormones in the Development of Human Breast Cancer , 1979 .
[19] B. Potter,et al. 17β‐hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone‐dependent breast cancer , 2008 .
[20] G. Palumbo,et al. 17β-Estradiol Inhibits Apoptosis in MCF-7 Cells, Inducing bcl-2 Expression via Two Estrogen-Responsive Elements Present in the Coding Sequence , 2000, Molecular and Cellular Biology.
[21] R. Shi,et al. Cofactor Hydrogen Bonding onto the Protein Main Chain Is Conserved in the Short Chain Dehydrogenase/Reductase Family and Contributes to Nicotinamide Orientation* , 2004, Journal of Biological Chemistry.
[22] Noriaki Ohuchi,et al. Sex steroid-producing enzymes in human breast cancer. , 2005, Endocrine-related cancer.
[23] A. León,et al. Androgens and androgen receptors in breast cancer , 2007, Journal of Steroid Biochemistry and Molecular Biology.
[24] R. Bhatnagar,et al. RNA Interference: Biology, Mechanism, and Applications , 2003, Microbiology and Molecular Biology Reviews.
[25] M. Poutanen,et al. Characterization of estrogen‐dependent growth of cultured MCF‐7 human breast‐cancer cells expressing 17β‐hydroxysteroid dehydrogenase type 1 , 1996 .
[26] R. Campbell,et al. Crystal structure of human estrogenic 17β-hydroxysteroid dehydrogenase complexed with 17β-estradiol , 1996, Nature Structural Biology.
[27] J. Thomsen,et al. Mechanisms of estrogen action. , 2001, Physiological reviews.
[28] A. Jemal,et al. Global Cancer Statistics , 2011 .
[29] J. Deslypere,et al. Steroid dynamics in the normal and carcinomatous mammary gland. , 1986, Journal of steroid biochemistry.
[30] B. Shenton,et al. The proliferative effects of 5-androstene-3β,17β-diol and 5α-dihydrotestosterone on cell cycle analysis and cell proliferation in MCF7, T47D and MDAMB231 breast cancer cell lines , 2004, The Journal of Steroid Biochemistry and Molecular Biology.
[31] B. Potter,et al. 17β-Hydroxysteroid dehydrogenase Type 1 and Type 2: Association between mRNA expression and activity in cell lines , 2006, Molecular and Cellular Endocrinology.
[32] T. Hei,et al. Estrogen-induced breast cancer: alterations in breast morphology and oxidative stress as a function of estrogen exposure. , 2008, Toxicology and applied pharmacology.
[33] R. Hess,et al. Reproductive Biology and Endocrinology Effects of 3-beta-diol, an Androgen Metabolite with Intrinsic Estrogen-like Effects, in Modulating the Aquaporin-9 Expression in the Rat Efferent Ductules , 2006 .
[34] Sheng-Xiang Lin,et al. Critical residues for the specificity of cofactors and substrates in human estrogenic 17beta-hydroxysteroid dehydrogenase 1: variants designed from the three-dimensional structure of the enzyme. , 2001, Molecular endocrinology.
[35] W. Pangborn,et al. Structure of human estrogenic 17 beta-hydroxysteroid dehydrogenase at 2.20 A resolution. , 1995, Structure.
[36] W. McGuire,et al. Human breast cancer: androgen action mediated by estrogen receptor. , 1978, Science.
[37] D. Poirier,et al. Synthesis and evaluation of estradiol derivatives with 16α-(bromoalkylamide), 16α-(bromoalkyl) or 16α-(bromoalkynyl) side chain as inhibitors of 17β-hydroxysteroid dehydrogenase type 1 without estrogenic activity , 1996 .
[38] R. Shi,et al. Pseudo‐symmetry of C19‐steroids, alternative binding orientations and multispecificity in human estrogenic 17β‐hydroxysteroid dehydrogenase , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[39] M. Lacroix,et al. Relevance of Breast Cancer Cell Lines as Models for Breast Tumours: An Update , 2004, Breast Cancer Research and Treatment.
[40] B. Schoultz. Androgens and the breast. , 2007 .
[41] D. Poirier,et al. Estradiol and estrone C-16 derivatives as inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: blocking of ER+ breast cancer cell proliferation induced by estrone. , 2008, Bioorganic & medicinal chemistry.
[42] J. Pasqualini. The selective estrogen enzyme modulators in breast cancer: a review. , 2004, Biochimica et biophysica acta.
[43] H. Rajaniemi,et al. A coupled one-step reverse transcription PCR procedure for generation of full-length open reading frames. , 1994, BioTechniques.
[44] Wanjin Tang,et al. Regulation of steroid hydroxylase CYP7B1 by androgens and estrogens in prostate cancer LNCaP cells. , 2006, Biochemical and biophysical research communications.
[45] G. Ossenkoppele,et al. A tetrazolium-based colorimetric MTT assay to quantitate human monocyte mediated cytotoxicity against leukemic cells from cell lines and patients with acute myeloid leukemia. , 1994, Journal of immunological methods.
[46] M. Hinkhouse,et al. The hydrolysis of estrone sulfate and dehydroepiandrosterone sulfate by MCF-7 human breast cancer cells. , 1988, Endocrinology.
[47] A. Segaloff. Hormones and Mammary Carcinogenesis , 1978 .
[48] M. Sikora,et al. The androgen metabolite 5α-androstane-3β,17β-diol (3βAdiol) induces breast cancer growth via estrogen receptor: implications for aromatase inhibitor resistance , 2009, Breast Cancer Research and Treatment.
[49] Jean Cumps,et al. Improved real-time RT-PCR method for high-throughput measurements using second derivative calculation and double correction. , 2005, BioTechniques.
[50] G. Chetrite,et al. Transformation of estrone and estradiol in hormone-dependent and hormone-independent human breast cancer cells , 1995, Breast Cancer Research and Treatment.
[51] O. Stål,et al. Proliferative responses to altered 17beta-hydroxysteroid dehydrogenase (17HSD) type 2 expression in human breast cancer cells are dependent on endogenous expression of 17HSD type 1 and the oestradiol receptors. , 2006, Endocrine-related cancer.
[52] J. Yates,et al. Interaction of the tumor metastasis suppressor nonmetastatic protein 23 homologue H1 and estrogen receptor alpha alters estrogen-responsive gene expression. , 2007, Cancer research.
[53] Sheng-Xiang Lin,et al. Subunit identity of the dimeric 17 beta-hydroxysteroid dehydrogenase from human placenta. , 1992, The Journal of biological chemistry.
[54] W. Pangborn,et al. Crystallization and preliminary X-ray diffraction analysis of the complex of human placental 17 beta-hydroxysteroid dehydrogenase with NADP+. , 1993, Journal of molecular biology.
[55] J. Bentel,et al. Inhibition of MCF-7 breast cancer cell proliferation by 5alpha-dihydrotestosterone; a role for p21(Cip1/Waf1). , 2004, Journal of molecular endocrinology.
[56] G. Chetrite,et al. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer , 2005, The Journal of Steroid Biochemistry and Molecular Biology.
[57] J. Simard,et al. Androgen receptor-mediated stimulation of 17 beta-hydroxysteroid dehydrogenase activity by dihydrotestosterone and medroxyprogesterone acetate in ZR-75-1 human breast cancer cells. , 1993, Endocrinology.